Clinical Team
Ono Pharmaceutical Co., Ltd. · Deciphera Pharmaceuticals, LLC · Therakos LLC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
50
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers in non-small cell lung cancer
0
PubMed author-name match
Trials
Studies that name Clinical Team as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:12 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07825402 · A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)Ono Pharmaceutical Co., Ltd. · not yet recruiting · Multiple System Atrophy, Parkinson Variant · study director
- Ph3NCT07818070 · A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal AdenocarcinomaOno Pharmaceutical Co., Ltd. · not yet recruiting · Gastric Cancer, Esophagogastric Junction Cancer, Esophageal Adenocarcinoma · study director
- Ph1NCT07744802 · Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male ParticipantsDeciphera Pharmaceuticals, LLC · recruiting · Healthy Male Participants · study director
- Ph1NCT07539090 · Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)Deciphera Pharmaceuticals, LLC · completed · Healthy Participants · study director
- Ph3NCT07429266 · INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)Ono Pharmaceutical Co., Ltd. · recruiting · Polycythemia Vera · study director
- Ph1NCT07158398 · Evaluate the Effect of Vimseltinib on the Pharmacokinetics of a BCRP and OATP1B1 SubstrateDeciphera Pharmaceuticals, LLC · completed · Healthy Participants · study director
- Ph1NCT07158411 · Evaluate the Effect of Vimseltinib on Organic Cation Transporter 2 (OCT2)Deciphera Pharmaceuticals, LLC · completed · Healthy Participants · study director
- Ph3NCT07104032 · IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)Ono Pharmaceutical Co., Ltd. · recruiting · Relapsed/Refractory Primary Central Nervous System Lymphoma · study director
- N/ANCT07075471 · MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With VimseltinibDeciphera Pharmaceuticals, LLC · recruiting · Tenosynovial Giant Cell Tumor · study director
- Ph1NCT06966024 · Study of DCC-2812 in Participants With Advanced Genitourinary CancersDeciphera Pharmaceuticals, LLC · recruiting · Renal Cell Carcinoma, Urothelial Carcinoma, Castration-resistant Prostate Cancer · study director
- Ph2NCT06646016 · EPIC- Extracorporeal Photopheresis (ECP) for Immune-related ColitisTherakos LLC · withdrawn · Immune-related Colitis · study director
- Ph1/Ph2NCT06630234 · A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)Deciphera Pharmaceuticals, LLC · recruiting · Gastrointestinal Stromal Tumor (GIST) · study director
- Ph2NCT06619561 · A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)Deciphera Pharmaceuticals, LLC · recruiting · Chronic Graft-Versus-Host Disease (cGVHD) · study director
- Ph1/Ph2NCT05957367 · A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced MalignanciesDeciphera Pharmaceuticals, LLC · active not recruiting · GIST · study director
- N/ANCT05769751 · A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast CancerDaiichi Sankyo · completed · HER2-positive Breast Cancer · study director
- Ph3NCT05734105 · A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With ImatinibDeciphera Pharmaceuticals, LLC · active not recruiting · GIST · study director
- Ph3NCT05517902 · StrataGraft Safety, Tolerability and Efficacy in Pediatric SubjectsStratatech, a Mallinckrodt Company · completed · Skin Wound, Burns, Trauma-related Wound · study director
- Ph1NCT05163691 · Pharmacokinetics of GH001 in Healthy VolunteersGH Research Ireland Limited · completed · Healthy Volunteers · study director
- Ph1NCT04892017 · Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid TumorsDeciphera Pharmaceuticals, LLC · terminated · Non-Small Cell Lung Cancer, Advanced Solid Tumor, Metastatic Solid Tumor · study director
- Ph1/Ph2NCT04765202 · StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal BurnsStratatech, a Mallinckrodt Company · terminated · Full Thickness Thermal Burn · study director
- Ph1/Ph2NCT04698603 · Clinical Study of GH001 in DepressionGH Research Ireland Limited · completed · Treatment Resistant Depression, Major Depressive Disorder, Depression · study director
- Ph1NCT04640831 · Safety of GH001 in Healthy VolunteersGH Research Ireland Limited · completed · Healthy Volunteers · study director
- Ph4NCT04526704 · Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With PexidartinibDaiichi Sankyo · completed · Tenosynovial Giant Cell Tumor · study director
- Ph3NCT04128462 · MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain FunctionMallinckrodt · withdrawn · Hepatic Encephalopathy · study director
- Ph1NCT03997734 · Tolerability, Safety and Pharmacokinetics of a Topical AB001 Patch in Healthy SubjectsFrontier Biotechnologies Inc. · completed · Chronic Low Back Pain · study director
- Ph1NCT03846843 · OCR002-SP103 - Oral Immediate Release StudyOcera Therapeutics, Inc. · completed · Cirrhosis · study director
- Ph2NCT03719664 · Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed SubjectsFrontier Biotechnologies Inc. · unknown · HIV-1-infection · study director
- Ph2NCT03712280 · MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)Mallinckrodt · completed · Hepatic Cirrhosis, Hepatic Encephalopathy (HE) · study director
- Ph4NCT03656692 · Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)Mallinckrodt · terminated · Uveitis, Posterior, Uveitis, Intermediate, Panuveitis · study director
- Ph1NCT03552029 · Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)Daiichi Sankyo · terminated · Acute Myeloid Leukemia · study director
- Ph4NCT03320070 · Acthar Gel in Participants With Pulmonary SarcoidosisMallinckrodt · completed · Sarcoidosis, Pulmonary · study director
- N/ANCT03132428 · Registry to Evaluate INOmax in Newborn Babies With Pulmonary HypertensionMallinckrodt · terminated · Pulmonary Hypertension of Newborn · study director
- Ph4NCT03126760 · Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)Mallinckrodt ARD LLC · terminated · Multiple Sclerosis, Relapsing-Remitting · study director
- Ph2/Ph3NCT03068754 · Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)Mallinckrodt · terminated · Amyotrophic Lateral Sclerosis · study director
- Ph3NCT03005106 · StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal ElementsStratatech, a Mallinckrodt Company · completed · Burn, Thermal · study director
- Ph4NCT02919761 · Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid ArthritisMallinckrodt · completed · Arthritis, Rheumatoid · study director
- Ph3NCT02770716 · Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1Mallinckrodt · completed · Hepatorenal Syndrome · study director
- Ph3NCT02766777 · Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional ConstipationSucampo Pharma Americas, LLC · completed · Constipation - Functional · study director
- Ph4NCT02633046 · Acthar for Treatment-Resistant or Treatment-Intolerant ProteinuriaMallinckrodt ARD LLC · completed · Idiopathic Focal Segmental Glomerulosclerosis · study director
- Ph3NCT02524847 · Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host DiseaseTherakos, Inc., a Mallinckrodt Company · terminated · Steroid Refractory Acute Graft Versus Host Disease · study director
- N/ANCT02484898 · SEEQ™ Performance StudyMedtronic Cardiac Rhythm and Heart Failure · completed · Arrhythmia Type Unknown · study director
- Ph2NCT02426086 · Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) InhibitorGeron Corporation · completed · Myelofibrosis · study director
- Ph3NCT02042183 · Lubiprostone in Children With Functional ConstipationSucampo Pharma Americas, LLC · completed · Constipation - Functional · study director
- Ph2NCT01966419 · Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)Ocera Therapeutics, Inc. · completed · Acute Episode of Overt Hepatic Encephalopathy, Hepatic Encephalopathy · study chair
- Ph2NCT01731951 · Imetelstat Sodium in Treating Participants With Primary or Secondary MyelofibrosisGeron Corporation · completed · Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies · study director
- Ph3NCT01635101 · A Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric PatientsMallinckrodt · completed · Acute Pain · study director
- Ph3NCT01143246 · A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With TerlipressinMallinckrodt · completed · Hepatorenal Syndrome · study director
- Ph2NCT00850993 · A Safety and Efficacy Trial of Stannsoporfin in Neonates With HyperbilirubinemiaInfaCare Pharmaceuticals Corporation, a Mallinckrodt Company · terminated · Hyperbilirubinemia, Neonatal · study director
- Ph3NCT00595946 · Opioid-induced Bowel Dysfunction: Pivotal Assessment of LubiprostoneSucampo Pharma Americas, LLC · completed · Opioid-Induced Bowel Dysfunction · study director
- Ph3NCT00551642 · Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature BabiesMallinckrodt · completed · Lung Disease · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.